:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Tuuli Kauppala, Tuomo Susi, Sangita Kulathinal
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Statistics in Medicine
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/sim.70421
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nonparametric Estimation of the Potential Impact Fraction and the Population Attributable Fraction With Individual‐Level and Aggregated Data
by: Colleen E. Chan, et al.
Published: (2025)

Spatial Individual‐Level Models for Transmission Dynamics of Seasonal Infectious Diseases
by: Amin Abed, et al.
Published: (2026)

Can the Unit Size Predict Outcomes? Testing for Informativeness in Three‐Level Designs
by: Samuel Anyaso‐Samuel, et al.
Published: (2025)

Cluster‐Level Analyses to Estimate a Risk Difference in a Cluster Randomized Trial With Confounding Individual‐Level Covariates: A Simulation Study
by: Jules Antoine Pereira Macedo, et al.
Published: (2025)

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials
by: Peter C. Austin
Published: (2026)

Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout
by: Analissa Avila, et al.
Published: (2025)

Network Meta‐Analysis With Individual Participant‐Level Data of Time‐to‐Event Outcomes Using Cox Regression
by: Kaiyuan Hua, et al.
Published: (2025)

Editorial
by: Sangita Kulathinal, et al.
Published: (2024)

Editorial
by: Sangita Kulathinal, et al.
Published: (2024)

Predicting Individual Risk of Advanced Adenoma Based on the Interval‐Censored Recurrent Adenoma Event and Informative Screening Time
by: Yipeng Wei, et al.
Published: (2026)

Collaborative Inference for Accelerated Failure Time Model Using Clinical Center‐Level Summary Statistics
by: Mengtong Hu, et al.
Published: (2025)

Modeling the Role of Baseline Risk and Additional Study‐Level Covariates in Meta‐Analysis of Treatment Effects
by: Phuc T. Tran, et al.
Published: (2025)

Testing and Quantifying Site‐Level Variability in Diagnostic Sensitivity of an Anchor Variable
by: Seungchul Baek, et al.
Published: (2026)

Bayesian Estimation of Hierarchical Linear Models From Incomplete Data: Cluster‐Level Interaction Effects and Small Sample Sizes
by: Dongho Shin, et al.
Published: (2025)

Expected Value of Sample Information Calculations for Risk Prediction Model Development
by: Abdollah Safari, et al.
Published: (2026)

Adaptive Incorporation of External Summary Information in the Cox Regression Under Population Heterogeneity
by: Yiqi Li, et al.
Published: (2026)

Semiparametric Partial Functional Regression Model for Estimating Optimal Individualized Treatment Regime
by: Kaidi Kong, et al.
Published: (2025)

BCH‐GEE Approach to Examine the Association Between Time‐Varying Food Environment Classes and Multi‐Level Health Outcomes
by: Kelsey A. L. Alexovitz, et al.
Published: (2026)

Extending the Median Odds Ratio ( MOR ), the Interval Odds Ratio ( IOR ), and the Proportion of Opposed Odds Ratios ( POOR ) for Use With 3‐Level Multilevel Logistic Regression Models
by: Peter C. Austin, et al.
Published: (2026)

Information‐Based Composite Likelihood Method for Hybrid Meta‐Analysis Integrating Individual Participant Data and Aggregated Data
by: Guoqing Diao, et al.
Published: (2026)

Jointly Modeling Time‐To‐Event and Longitudinal Data With Individual‐Specific Change Points: A Case Study in Modeling Tumor Burden
by: Ethan M. Alt, et al.
Published: (2025)

Individualized empirical null estimation for exact tests of healthcare quality
by: Nicholas Hartman, et al.
Published: (2024)

Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference
by: Ziyu Ji, et al.
Published: (2024)

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
by: Konstantinos Sechidis, et al.
Published: (2025)

Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
by: Rebecca B. Silva, et al.
Published: (2024)

Probabilistic Clustering Using Multivariate Growth Mixture Model in Clinical Settings—A Scleroderma Example
by: Ji Soo Kim, et al.
Published: (2026)

A Bayesian Location‐Scale Joint Model for Time‐To‐Event and Multivariate Longitudinal Data With Association Based on Within‐Individual Variability
by: Marco Palma, et al.
Published: (2026)

Instability of the AUROC of Clinical Prediction Models
by: Florian D. van Leeuwen, et al.
Published: (2025)

Scaled average bioequivalence methods for highly variable drugs: Leveling‐off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control)
by: Joel Muñoz, et al.
Published: (2024)

Variant‐Specific Mendelian Risk Prediction Model
by: Julie‐Alexia Dias, et al.
Published: (2025)

Model Validation for Survival Analysis by Smoothed Predictive Likelihood
by: Chengyuan Lu, et al.
Published: (2025)

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
by: Xi Fang, et al.
Published: (2026)

Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall Survival
by: Georgios Kazantzidis, et al.
Published: (2026)

Validation of a Risk‐Prediction Model in the Presence of Outcome Misclassification
by: Runjia Zou, et al.
Published: (2026)

A Personalized Predictive Model That Jointly Optimizes Discrimination and Calibration
by: Tatiana Krikella, et al.
Published: (2025)

Constructing a T ‐Test for Value Function Comparison of Individualized Treatment Regimes in the Presence of Multiple Imputation for Missing Data
by: Minxin Lu, et al.
Published: (2025)

Combining Missing Data Imputation and Internal Validation in Clinical Risk Prediction Models
by: Junhui Mi, et al.
Published: (2025)

Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions
by: Hannah Klinkhammer, et al.
Published: (2024)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
by: Jingyan Fu, et al.
Published: (2025)

Overview and Practical Recommendations on Using Shapley Values for Identifying Predictive Biomarkers via CATE Modeling
by: David Svensson, et al.
Published: (2026)